|
市場調査レポート
商品コード
1530290
アルファリポ酸の市場規模、シェア、動向分析レポート：製品別、用途別、地域別、セグメント予測、2024年～2030年Alpha-lipoic Acid Market Size, Share & Trends Analysis Report By Product (R Alpha Lipoic Acid, S Alpha Lipoic Acid), By Application (Dietary Supplements, Cosmetics), By Region, And Segment Forecasts, 2024 - 2030 |
||||||
カスタマイズ可能
|
|||||||
| アルファリポ酸の市場規模、シェア、動向分析レポート：製品別、用途別、地域別、セグメント予測、2024年～2030年 |
|
出版日: 2024年07月17日
発行: Grand View Research
ページ情報: 英文 90 Pages
納期: 2～10営業日
|
- 全表示
- 概要
- 図表
- 目次
アルファリポ酸市場の成長と動向
Grand View Research社の最新レポートによると、アルファリポ酸の世界市場規模は2024年から2030年にかけてCAGR6.2%で成長し、2030年には14億8,000万米ドルに達すると推定されました。α-リポ酸（ALA）は強力な抗酸化物質であり、フリーラジカルによるダメージから細胞を保護するのに役立ちます。炎症を抑え、ミトコンドリア機能を改善することで、老化プロセスを遅らせることが示されています。アンチエイジング・サプリメントの利点に対する消費者の認識が高まるにつれ、ALAの需要は拡大すると予想されます。世界銀行によると、欧州では2050年までに65歳以上の人口の割合が25％を超えるといいます。
糖尿病、心血管疾患、神経障害などの慢性疾患の有病率の上昇は、ALA市場の主要な促進要因です。消費者がこれらの疾患を管理するための自然な解決策を求める中、代謝機能を改善し、酸化ストレスを軽減し、全体的な健康をサポートするALAの可能性が大きな関心を集めています。この動向は、食生活と健康との関連性に対する意識の高まりによってさらに増幅され、ALAのような天然サプリメントを探求する個人を後押ししています。さらに、eコマース・プラットフォームやオンライン・ヘルス＆ウェルネス・コミュニティーの台頭は、ALAに関するより大きなアクセスと情報を提供し、市場の成長をさらに後押ししています。
2023年のアルファ・リポ酸市場では、R-アルファ・リポ酸（R-ALA）セグメントが大きなシェアを占めています。R-ALAは天然に存在するα-リポ酸のエナンチオマーであり、優れた生物学的利用能と抗酸化特性により、酸化ストレスの軽減と健康全般の改善に効果的であるとして、特に注目されています。認知機能をサポートし、慢性疾患のリスクを軽減し、エネルギー産生を強化するその能力は、健康志向の消費者の間でその人気を牽引しています。さらに、自然で効果的な栄養補助食品に対する消費者の嗜好の高まりが、R-ALAの需要を押し上げています。さらに、カプセル、錠剤、粉末など、さまざまな剤形でのR-ALAの利用が可能になりつつあることも、同分野の成長をさらに押し上げると予想されます。
栄養補助食品分野は2023年にα-リポ酸市場で大きなシェアを占めたが、これはその多くの健康上の利点に対する消費者の意識の高まりと予防的ヘルスケアアプローチの採用増加によるものです。ALAを配合したサプリメントの需要が急増したのは、その強力な抗酸化特性によるもので、酸化ストレスと闘い、細胞の保護を強化すると考えられています。さらに、ALAにはインスリン感受性とグルコース代謝を改善する可能性があるため、血糖値の管理や健康的な加齢の促進を求める人々の間で大きな注目を集めています。糖尿病と代謝障害の有病率の増加は、この需要をさらに増幅させています。
2023年の市場シェアは北米が最大でした。北米では、糖尿病、肥満、心血管疾患などの慢性疾患の有病率が上昇傾向にあります。これらの疾患は酸化ストレスや炎症の増加と関連しており、α-リポ酸によって緩和される可能性があります。慢性疾患の治療効果が期待されることから、同地域での需要に拍車がかかりそうです。さらに、FDA（食品医薬品局）はα-リポ酸にGRAS（Generally Recognized as Safe：一般に安全と認められる）ステータスを付与しており、栄養補助食品や機能性食品のメーカーにとって魅力的な原料となっています。良好な規制の枠組みは、市場成長のための安定した環境を提供しています。
市場の主要プレーヤーは、新製品発売、提携、M&A、世界展開など、市場シェア拡大のためにさまざまな手段を講じています。また、従来の小売チャネルをバイパスして消費者に直接販売するため、強力なオンライン販売チャネルを構築しています。
アルファリポ酸市場レポート・ハイライト
- アジア太平洋地域は、堅調な経済成長と可処分所得の増加により、2024年から2030年にかけてかなりのCAGRで成長すると予想されています。その結果、ALAを含むサプリメントや栄養補助食品への支出が増加しています。
- S-αリポ酸セグメントは、2024年から2030年まで大幅なCAGRで成長すると推定されています。S-αリポ酸は強力な抗酸化物質であり、エネルギー生産、解毒、酸化ストレスの軽減に重要な役割を果たします。血糖値を調整し、インスリン感受性を改善する能力もあるため、減量サプリメントの成分としても人気があります。
- 化粧品分野は、効果的なアンチエイジング、抗酸化、美肌ソリューションに対する需要の増加により、2024年から2030年にかけて大幅なCAGRで成長すると推定されます。この動向に拍車をかけているのは、紫外線、汚染、ライフスタイルの選択といった環境ストレスが肌の健康に及ぼす悪影響に対する意識の高まりで、消費者は肌を保護し活性化させる製品を求めるようになっています。
目次
第1章 調査手法と範囲
第2章 エグゼクティブサマリー
第3章 アルファリポ酸市場の変数、動向、範囲
- 市場系統の見通し
- 業界バリューチェーン分析
- 販売/小売チャネル分析
- 利益率分析
- 市場力学
- 市場 促進要因分析
- 市場抑制要因分析
- 市場機会
- 市場の課題
- 業界分析- ポーターのファイブフォース分析
- 市場参入戦略
第4章 アルファリポ酸市場：製品推定・動向分析
- 製品変動分析と市場シェア、2023年と2030年
- Rアルファリポ酸
- Sアルファリポ酸
第5章 アルファリポ酸市場：用途推定・動向分析
- 用途変動分析と市場シェア、2023年と2030年
- 栄養補助食品
- 化粧品
- 医薬品
- その他
第6章 アルファリポ酸市場：地域推定・動向分析
- 地域変動分析と市場シェア、2023年と2030年
- 北米
- 市場推計・予測、2018年-2030年
- 製品別、2018年-2030年
- 用途別、2018年-2030年
- 米国
- カナダ
- メキシコ
- 欧州
- 市場推計・予測、2018年-2030年
- 製品別、2018年-2030年
- 用途別、2018年-2030年
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- アジア太平洋
- 市場推計・予測、2018年-2030年
- 製品別、2018年-2030年
- 用途別、2018年-2030年
- 中国
- 日本
- インド
- 韓国
- オーストラリアとニュージーランド
- 中南米
- 市場推計・予測、2018年-2030年
- 製品別、2018年-2030年
- 用途別、2018年-2030年
- ブラジル
- 中東・アフリカ
- 市場推計・予測、2018年-2030年
- 製品別、2018年-2030年
- 用途別、2018年-2030年
- 南アフリカ
第7章 競合分析
- 主要市場参入企業による最近の動向と影響分析
- 企業分類
- 参入企業の概要
- 財務実績
- 製品ベンチマーク
- 企業市場シェア分析、2023年（％）
- 企業ヒートマップ分析
- 戦略マッピング
- 企業プロファイル
- AlzChem Group AG
- GeroNova Research Inc.
- Haihang Industry
- Bio Actives Japan Corporation
- Prinova Group LLC.
- Olon SpA
- Spectrum Chemical
- K.-W. Pfannenschmidt GmbH
- Suzhou Fushilai Pharmaceutical Co. Ltd.
- Xi'an Green Spring Technology Co., Ltd
List of Tables
- 1. Alpha-lipoic acid market - Key market driver analysis
- 2. Alpha-lipoic acid market - Key market restraint analysis
- 3. R alpha lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 4. S alpha lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 5. Alpha-lipoic acid market estimates and forecast from dietary supplements application, 2018 - 2030 (USD Million)
- 6. Alpha-lipoic acid market estimates and forecast from cosmetics application, 2018 - 2030 (USD Million)
- 7. Alpha-lipoic acid market estimates and forecast from pharmaceuticals application, 2018 - 2030 (USD Million)
- 8. Alpha-lipoic acid market estimates and forecast from other applications, 2018 - 2030 (USD Million)
- 9. North America alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 10. North America alpha-lipoic acid market estimates and forecast by product, 2018 - 2030 (USD Million)
- 11. North America alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
- 12. U.S. macro-economic outlay
- 13. U.S. alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 14. U.S. alpha-lipoic acid market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
- 15. U.S. alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
- 16. Canada macro-economic outlay
- 17. Canada alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 18. Canada alpha-lipoic acid market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
- 19. Canada alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
- 20. Mexico macro-economic outlay
- 21. Mexico alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 22. Mexico alpha-lipoic acid market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
- 23. Mexico alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
- 24. Europe alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 25. Europe alpha-lipoic acid market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
- 26. Europe alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
- 27. Germany macro-economic outlay
- 28. Germany alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 29. Germany alpha-lipoic acid market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
- 30. Germany alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
- 31. UK macro-economic outlay
- 32. UK alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 33. UK alpha-lipoic acid market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
- 34. UK alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
- 35. France macro-economic outlay
- 36. France alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 37. France alpha-lipoic acid market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
- 38. France alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
- 39. Italy macro-economic outlay
- 40. Italy alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 41. Italy alpha-lipoic acid market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
- 42. Italy alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
- 43. Spain macro-economic outlay
- 44. Spain alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 45. Spain alpha-lipoic acid market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
- 46. Spain alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
- 47. Asia Pacific alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 48. Asia Pacific alpha-lipoic acid market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
- 49. Asia Pacific alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
- 50. China macro-economic outlay
- 51. China alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 52. China alpha-lipoic acid market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
- 53. China alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
- 54. India macro-economic outlay
- 55. India alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 56. India alpha-lipoic acid market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
- 57. India alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
- 58. Japan macro-economic outlay
- 59. Japan alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 60. Japan alpha-lipoic acid market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
- 61. Japan alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
- 62. Australia & New Zealand macro-economic outlay
- 63. Australia & New Zealand alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 64. Australia & New Zealand alpha-lipoic acid market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
- 65. Australia & New Zealand alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
- 66. South Korea macro-economic outlay
- 67. South Korea alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 68. South Korea alpha-lipoic acid market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
- 69. South Korea alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
- 70. South & Central America alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 71. South & Central America alpha-lipoic acid market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
- 72. South & Central America alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
- 73. Brazil macro-economic outlay
- 74. Brazil alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 75. Brazil alpha-lipoic acid market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
- 76. Brazil alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
- 77. Middle East & Africa alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 78. Middle East & Africa alpha-lipoic acid market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
- 79. Middle East & Africa alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
- 80. South Africa macro-economic outlay
- 81. South Africa alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 82. South Africa alpha-lipoic acid market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
- 83. South Africa alpha-lipoic acid market estimates and forecast by application, 2018 - 2030 (USD Million)
List of Figures
- 1. Alpha-lipoic acid market snapshot
- 2. Alpha-lipoic acid market segmentation & scope
- 3. Alpha-lipoic acid market value chain analysis
- 4. Alpha-lipoic acid market dynamics
- 5. Alpha-lipoic acid market Porter's Five Forces analysis
- 6. R alpha lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 7. S alpha lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 8. Alpha-lipoic acid market estimates and forecast from dietary supplements application, 2018 - 2030 (USD Million)
- 9. Alpha-lipoic acid market estimates and forecast from cosmetics application, 2018 - 2030 (USD Million)
- 10. Alpha-lipoic acid market estimates and forecast from pharmaceuticals application, 2018 - 2030 (USD Million)
- 11. Alpha-lipoic acid market estimates and forecast from other applications, 2018 - 2030 (USD Million)
- 12. Alpha-lipoic acid market: Regional movement analysis, 2023 & 2030 (%)
- 13. North America alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 14. U.S. alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 15. Canada alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 16. Mexico alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 17. Europe alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 18. Germany alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 19. UK alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 20. Spain alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 21. Italy alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 22. France alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 23. Asia Pacific alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 24. China alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 25. India alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 26. Japan alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 27. South Korea alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 28. Australia & New Zealand alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 29. Central & South America alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 30. Brazil alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 31. Middle East & Africa alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
- 32. South Africa alpha-lipoic acid market estimates and forecast, 2018 - 2030 (USD Million)
Alpha-lipoic Acid Market Growth &Trends
The global alpha-lipoic acid market size was estimated to reach USD 1.48 billion in 2030, growing at a CAGR of 6.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Alpha-lipoic acid (ALA) is a powerful antioxidant that helps protect cells from free radical damage. It has been shown to slow the aging process by reducing inflammation and improving mitochondrial function. As consumers become increasingly aware of the benefits of anti-aging supplements, the demand for ALA is expected to grow. According to the World Bank, the proportion of people over 65 in Europe will exceed 25 percent by 2050.
The rising prevalence of chronic diseases such as diabetes, cardiovascular disease, and neurological disorders is a key driver of the ALA market. As consumers seek natural solutions to manage these conditions, ALA's potential to improve metabolic function, reduce oxidative stress, and support overall well-being is attracting considerable interest. This trend is further amplified by the increasing awareness of the link between diet and health, encouraging individuals to explore natural supplements like ALA. Moreover, the rise of e-commerce platforms and online health and wellness communities are providing greater accessibility and information about ALA, further propelling market growth.
The R alpha lipoic acid (R-ALA) segment held a major share of the alpha-lipoic acid market in 2023. R-ALA is a naturally occurring enantiomer of alpha-lipoic acid and is particularly sought after for its superior bioavailability and antioxidant properties, making it effective in reducing oxidative stress and improving overall health. Its ability to support cognitive function, reduce the risk of chronic diseases, and enhance energy production is driving its popularity among health-conscious consumers. Moreover, the growing consumer preference for natural and effective dietary supplements is boosting the demand for R-ALA. Besides, the increasing availability of R-ALA in various dosage forms, including capsules, tablets, and powders, is anticipated to further boost the segment growth.
The dietary supplements segment held a major share of the alpha-lipoic acid market in 2023, driven by escalating consumer awareness of its numerous health benefits and the increasing adoption of a preventative healthcare approach. The demand for ALA-infused supplements has surged due to their potent antioxidant properties, which are believed to combat oxidative stress and enhance cellular protection. Moreover, ALA's potential to improve insulin sensitivity and glucose metabolism has garnered significant attention among individuals seeking to manage their blood sugar levels or promote healthy aging. The growing prevalence of diabetes and metabolic disorders further amplifies this demand.
North America accounted for the largest share of the market in 2023. The prevalence of chronic diseases such as diabetes, obesity, and cardiovascular diseases is on the rise in North America. These conditions are associated with increased oxidative stress and inflammation, which can be potentially mitigated by alpha-lipoic acid. Its therapeutic potential in managing chronic diseases is likely to fuel demand in the region. Moreover, the Food and Drug Administration (FDA) has granted Generally Recognized as Safe (GRAS) status to alpha-lipoic acid, making it an attractive ingredient for manufacturers of dietary supplements and functional foods. The favorable regulatory framework provides a stable environment for market growth.
Key market players are implementing various steps including new product launches, partnerships, mergers & acquisitions, global expansion, and others to gain more share of the market. They are building strong online sales channels to sell directly to consumers, bypassing traditional retail channels.
Alpha-lipoic Acid Market Report Highlights:
- Asia Pacific is expected to grow with a considerable CAGR from 2024 to 2030, driven by robust economic growth and increased disposable income, allowing consumers to allocate more resources towards health and wellness. This has resulted in increased spending on supplements and nutraceuticals, including ALA.
- The S-Alpha Lipoic Acid segment is estimated to grow with a substantial CAGR from 2024 to 2030. S-alpha lipoic acid is a potent antioxidant that plays a crucial role in energy production, detoxification, and reducing oxidative stress. Its ability to regulate blood sugar levels and improve insulin sensitivity has also made it a popular ingredient in weight loss supplements.
- The cosmetics segment is estimated to grow with a substantial CAGR from 2024 to 2030, driven by an increasing demand for effective anti-aging, antioxidant, and skin-brightening solutions. This trend is fueled by a growing awareness of the harmful effects of environmental stressors like UV radiation, pollution, and lifestyle choices on skin health, leading consumers to seek out products that protect and revitalize their skin.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Introduction Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Introduction Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Product Outlook
- 2.3. Application Outlook
- 2.4. Regional Outlook
Chapter 3. Alpha-Lipoic Acid Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.2. Industry Value Chain Analysis
- 3.2.1. Sales/Retail Channel Analysis
- 3.2.2. Profit Margin Analysis
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.3.3. Market Opportunities
- 3.3.4. Market Challenges
- 3.4. Industry Analysis - Porter's Five Forces Analysis
- 3.5. Market Entry Strategies
Chapter 4. Alpha-Lipoic Acid Market: Product Estimates & Trend Analysis
- 4.1. Product Movement Analysis & Market Share, 2023 & 2030
- 4.2. R Alpha Lipoic Acid
- 4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3. S Alpha Lipoic Acid
- 4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5. Alpha-Lipoic Acid Market: Application Estimates & Trend Analysis
- 5.1. Application Movement Analysis & Market Share, 2023 & 2030
- 5.2. Dietary Supplements
- 5.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3. Cosmetics
- 5.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.4. Pharmaceuticals
- 5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.5. Others
- 5.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. Alpha-Lipoic Acid Market: Regional Estimates & Trend Analysis
- 6.1. Regional Movement Analysis & Market Share, 2023 & 2030
- 6.2. North America
- 6.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.2.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.2.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
- 6.2.4. U.S.
- 6.2.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.2.4.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.2.4.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
- 6.2.5. Canada
- 6.2.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.2.5.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.2.5.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
- 6.2.6. Mexico
- 6.2.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.2.6.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.2.6.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
- 6.3. Europe
- 6.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.3.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
- 6.3.4. UK
- 6.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.4.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.3.4.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
- 6.3.5. Germany
- 6.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.5.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.3.5.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
- 6.3.6. France
- 6.3.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.6.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.3.6.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
- 6.3.7. Italy
- 6.3.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.7.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.3.7.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
- 6.3.8. Spain
- 6.3.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.8.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.3.8.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
- 6.4. Asia Pacific
- 6.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.4.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
- 6.4.4. China
- 6.4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.4.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.4.4.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
- 6.4.5. Japan
- 6.4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.5.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.4.5.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
- 6.4.6. India
- 6.4.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.6.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.4.6.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
- 6.4.7. South Korea
- 6.4.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.7.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.4.7.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
- 6.4.8. Australia & New Zealand
- 6.4.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.8.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.4.8.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
- 6.5. Central & South America
- 6.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.5.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
- 6.5.4. Brazil
- 6.5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.4.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.5.4.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
- 6.6. Middle East & Africa
- 6.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.6.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
- 6.6.4. South Africa
- 6.6.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6.4.2. Market estimates and forecast, by product, 2018 - 2030 (USD Million)
- 6.6.4.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
Chapter 7. Competitive Analysis
- 7.1. Recent developments & impact analysis, by key market participants
- 7.2. Company Categorization
- 7.3. Participant's Overview
- 7.4. Financial Performance
- 7.5. Product Benchmarking
- 7.6. Company Market Share Analysis, 2023 (%)
- 7.7. Company Heat Map Analysis
- 7.8. Strategy Mapping
- 7.9. Company Profiles
- 7.9.1. AlzChem Group AG
- 7.9.1.1. Company Overview
- 7.9.1.2. Financial Performance
- 7.9.1.3. Product Portfolios
- 7.9.1.4. Strategic Initiatives
- 7.9.2. GeroNova Research Inc.
- 7.9.2.1. Company Overview
- 7.9.2.2. Financial Performance
- 7.9.2.3. Product Portfolios
- 7.9.2.4. Strategic Initiatives
- 7.9.3. Haihang Industry
- 7.9.3.1. Company Overview
- 7.9.3.2. Financial Performance
- 7.9.3.3. Product Portfolios
- 7.9.3.4. Strategic Initiatives
- 7.9.4. Bio Actives Japan Corporation
- 7.9.4.1. Company Overview
- 7.9.4.2. Financial Performance
- 7.9.4.3. Product Portfolios
- 7.9.4.4. Strategic Initiatives
- 7.9.5. Prinova Group LLC.
- 7.9.5.1. Company Overview
- 7.9.5.2. Financial Performance
- 7.9.5.3. Product Portfolios
- 7.9.5.4. Strategic Initiatives
- 7.9.6. Olon S.p.A
- 7.9.6.1. Company Overview
- 7.9.6.2. Financial Performance
- 7.9.6.3. Product Portfolios
- 7.9.6.4. Strategic Initiatives
- 7.9.7. Spectrum Chemical
- 7.9.7.1. Company Overview
- 7.9.7.2. Financial Performance
- 7.9.7.3. Product Portfolios
- 7.9.7.4. Strategic Initiatives
- 7.9.8. K.-W. Pfannenschmidt GmbH
- 7.9.8.1. Company Overview
- 7.9.8.2. Financial Performance
- 7.9.8.3. Product Portfolios
- 7.9.8.4. Strategic Initiatives
- 7.9.9. Suzhou Fushilai Pharmaceutical Co. Ltd.
- 7.9.9.1. Company Overview
- 7.9.9.2. Financial Performance
- 7.9.9.3. Product Portfolios
- 7.9.9.4. Strategic Initiatives
- 7.9.10. Xi'an Green Spring Technology Co., Ltd
- 7.9.10.1. Company Overview
- 7.9.10.2. Financial Performance
- 7.9.10.3. Product Portfolios
- 7.9.10.4. Strategic Initiatives
- 7.9.1. AlzChem Group AG
